Page last updated: 2024-10-25

chlorthalidone and Basal Ganglia Diseases

chlorthalidone has been researched along with Basal Ganglia Diseases in 1 studies

Chlorthalidone: A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"A 52-year-old woman developed severe hyponatremia following treatment for hypertension with chlorthalidone."3.68Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. ( Goldhammer, Y; Sadeh, M, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sadeh, M1
Goldhammer, Y1

Other Studies

1 other study available for chlorthalidone and Basal Ganglia Diseases

ArticleYear
Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis.
    European neurology, 1993, Volume: 33, Issue:1

    Topics: Basal Ganglia Diseases; Biperiden; Carbidopa; Chlorthalidone; Coma; Drug Therapy, Combination; Femal

1993